Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Lindauer and colleagues set out to evaluate whether the tumor-free distance from the uterine serosa to the deepest invasive lesion was a better predictor of patient outcome from endometrial cancer than the traditional measure of myometrial invasion. To do this, they retrospectively evaluated all surgically staged endometrial adenocarcinoma patients between 1997 and 2000.

Myometrial Invasion and the Tumor-Free Distance from the Uterine Serosa in Endometrial Cancer?